---
layout: default
title: LLM-driven Knowledge Enhancement for Multimodal Cancer Survival Prediction
---

# LLM-driven Knowledge Enhancement for Multimodal Cancer Survival Prediction

**arXiv**: [2512.14594v1](https://arxiv.org/abs/2512.14594) | [PDF](https://arxiv.org/pdf/2512.14594.pdf)

**ä½œè€…**: Chenyu Zhao, Yingxue Xu, Fengtao Zhou, Yihui Wang, Hao Chen

**åˆ†ç±»**: cs.CV

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºKEMMæ¨¡åž‹ï¼Œé€šè¿‡LLMé©±åŠ¨çš„çŸ¥è¯†å¢žå¼ºè§£å†³å¤šæ¨¡æ€ç™Œç—‡ç”Ÿå­˜é¢„æµ‹ä¸­çš„ç‰¹å¾å†—ä½™å’Œå¯¹é½éš¾é¢˜ã€‚**

**å…³é”®è¯**: `å¤šæ¨¡æ€å­¦ä¹ ` `ç™Œç—‡ç”Ÿå­˜é¢„æµ‹` `çŸ¥è¯†å¢žå¼º` `LLMé©±åŠ¨` `è·¨æ¨¡æ€æ³¨æ„åŠ›` `ç—…ç†å›¾åƒåˆ†æž` `åŸºå› ç»„æ•°æ®` `é¢„åŽå»ºæ¨¡`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. çŽ°æœ‰æ–¹æ³•ä¾èµ–é«˜ç»´å†—ä½™çš„ç—…ç†å›¾åƒå’ŒåŸºå› ç»„æ•°æ®ï¼Œéš¾ä»¥æå–åˆ¤åˆ«æ€§ç‰¹å¾å¹¶å®žçŽ°æ¨¡æ€å¯¹é½ï¼Œä¸”ç”Ÿå­˜æ ‡ç­¾ç›‘ç£ä¸è¶³ã€‚
2. æå‡ºKEMMæ¨¡åž‹ï¼Œæ•´åˆLLMç²¾ç‚¼çš„ä¸“å®¶æŠ¥å‘Šå’Œç”Ÿæˆçš„é¢„åŽèƒŒæ™¯çŸ¥è¯†ï¼Œé€šè¿‡KECMæ³¨æ„åŠ›æ¨¡å—å¢žå¼ºç‰¹å¾æå–å’Œæ¨¡æ€èžåˆã€‚
3. åœ¨äº”ä¸ªæ•°æ®é›†ä¸Šå®žéªŒï¼ŒKEMMè¾¾åˆ°æœ€å…ˆè¿›æ€§èƒ½ï¼ŒéªŒè¯äº†çŸ¥è¯†å¢žå¼ºåœ¨å¤šæ¨¡æ€ç”Ÿå­˜é¢„æµ‹ä¸­çš„æœ‰æ•ˆæ€§ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

å½“å‰å¤šæ¨¡æ€ç”Ÿå­˜é¢„æµ‹æ–¹æ³•é€šå¸¸ä¾èµ–ç—…ç†å›¾åƒï¼ˆWSIsï¼‰å’ŒåŸºå› ç»„æ•°æ®ï¼Œè¿™äº›æ•°æ®å…·æœ‰é«˜ç»´åº¦å’Œå†—ä½™æ€§ï¼Œéš¾ä»¥ä»Žä¸­æå–åˆ¤åˆ«æ€§ç‰¹å¾å¹¶å®žçŽ°ä¸åŒæ¨¡æ€çš„å¯¹é½ã€‚æ­¤å¤–ï¼Œä»…ä½¿ç”¨ç®€å•çš„ç”Ÿå­˜éšè®¿æ ‡ç­¾ä¸è¶³ä»¥ç›‘ç£å¦‚æ­¤å¤æ‚çš„ä»»åŠ¡ã€‚ä¸ºè§£å†³è¿™äº›æŒ‘æˆ˜ï¼Œæˆ‘ä»¬æå‡ºäº†KEMMï¼Œä¸€ç§LLMé©±åŠ¨çš„çŸ¥è¯†å¢žå¼ºå¤šæ¨¡æ€æ¨¡åž‹ï¼Œç”¨äºŽç™Œç—‡ç”Ÿå­˜é¢„æµ‹ï¼Œè¯¥æ¨¡åž‹æ•´åˆäº†ä¸“å®¶æŠ¥å‘Šå’Œé¢„åŽèƒŒæ™¯çŸ¥è¯†ã€‚1ï¼‰ä¸“å®¶æŠ¥å‘Šç”±ç—…ç†å­¦å®¶é€æ¡ˆæä¾›ï¼Œå¹¶ç”±å¤§åž‹è¯­è¨€æ¨¡åž‹ï¼ˆLLMï¼‰ç²¾ç‚¼ï¼Œæä¾›ç®€æ´ä¸”ä¸´åºŠèšç„¦çš„è¯Šæ–­é™ˆè¿°ï¼Œè¿™äº›ä¿¡æ¯é€šå¸¸æš—ç¤ºä¸åŒçš„ç”Ÿå­˜ç»“æžœã€‚2ï¼‰é¢„åŽèƒŒæ™¯çŸ¥è¯†ï¼ˆPBKï¼‰ç”±LLMç®€æ´ç”Ÿæˆï¼Œæä¾›å…³äºŽä¸åŒç™Œç—‡ç±»åž‹çš„å®è´µé¢„åŽèƒŒæ™¯çŸ¥è¯†ï¼Œä»Žè€Œå¢žå¼ºç”Ÿå­˜é¢„æµ‹ã€‚ä¸ºåˆ©ç”¨è¿™äº›çŸ¥è¯†ï¼Œæˆ‘ä»¬å¼•å…¥äº†çŸ¥è¯†å¢žå¼ºè·¨æ¨¡æ€ï¼ˆKECMï¼‰æ³¨æ„åŠ›æ¨¡å—ã€‚KECMèƒ½æœ‰æ•ˆå¼•å¯¼ç½‘ç»œå…³æ³¨æ¥è‡ªé«˜åº¦å†—ä½™æ¨¡æ€çš„åˆ¤åˆ«æ€§å’Œç”Ÿå­˜ç›¸å…³ç‰¹å¾ã€‚åœ¨äº”ä¸ªæ•°æ®é›†ä¸Šçš„å¹¿æ³›å®žéªŒè¡¨æ˜Žï¼ŒKEMMå®žçŽ°äº†æœ€å…ˆè¿›çš„æ€§èƒ½ã€‚ä»£ç å°†åœ¨æŽ¥å—åŽå‘å¸ƒã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

KEMMçš„æ•´ä½“æ¡†æž¶æ˜¯ä¸€ä¸ªå¤šæ¨¡æ€æ·±åº¦å­¦ä¹ æ¨¡åž‹ï¼Œæ ¸å¿ƒæ•´åˆç—…ç†å›¾åƒã€åŸºå› ç»„æ•°æ®ã€ä¸“å®¶æŠ¥å‘Šå’Œé¢„åŽèƒŒæ™¯çŸ¥è¯†ã€‚å…³é”®æŠ€æœ¯åˆ›æ–°ç‚¹åŒ…æ‹¬ï¼š1ï¼‰åˆ©ç”¨LLMç²¾ç‚¼ä¸“å®¶æŠ¥å‘Šä»¥æä¾›ä¸´åºŠèšç„¦çš„è¯Šæ–­ä¿¡æ¯ï¼›2ï¼‰LLMç”Ÿæˆé¢„åŽèƒŒæ™¯çŸ¥è¯†ä»¥è¡¥å……é¢†åŸŸçŸ¥è¯†ï¼›3ï¼‰è®¾è®¡çŸ¥è¯†å¢žå¼ºè·¨æ¨¡æ€ï¼ˆKECMï¼‰æ³¨æ„åŠ›æ¨¡å—ï¼Œè¯¥æ¨¡å—é€šè¿‡çŸ¥è¯†å¼•å¯¼æ³¨æ„åŠ›æœºåˆ¶ï¼Œæœ‰æ•ˆèšç„¦äºŽåˆ¤åˆ«æ€§å’Œç”Ÿå­˜ç›¸å…³ç‰¹å¾ï¼Œå‡å°‘å†—ä½™å¹²æ‰°ã€‚ä¸ŽçŽ°æœ‰æ–¹æ³•çš„ä¸»è¦åŒºåˆ«åœ¨äºŽï¼šçŽ°æœ‰æ–¹æ³•é€šå¸¸ä»…ä¾èµ–åŽŸå§‹å¤šæ¨¡æ€æ•°æ®å’Œç®€å•æ ‡ç­¾ï¼Œè€ŒKEMMå¼•å…¥å¤–éƒ¨çŸ¥è¯†æºï¼ˆä¸“å®¶æŠ¥å‘Šå’ŒPBKï¼‰ï¼Œå¹¶é€šè¿‡KECMå®žçŽ°çŸ¥è¯†é©±åŠ¨çš„ç‰¹å¾å¯¹é½å’Œèžåˆï¼Œä»Žè€Œæå‡æ¨¡åž‹é²æ£’æ€§å’Œé¢„æµ‹å‡†ç¡®æ€§ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

åœ¨äº”ä¸ªæ•°æ®é›†ä¸Šçš„å®žéªŒæ˜¾ç¤ºï¼ŒKEMMå®žçŽ°äº†æœ€å…ˆè¿›çš„æ€§èƒ½ï¼Œå…·ä½“æå‡æœªçŸ¥ï¼Œä½†éªŒè¯äº†çŸ¥è¯†å¢žå¼ºå’ŒKECMæ¨¡å—åœ¨å¤šæ¨¡æ€ç”Ÿå­˜é¢„æµ‹ä¸­çš„æœ‰æ•ˆæ€§ï¼Œæ˜¾è‘—ä¼˜äºŽä¾èµ–åŽŸå§‹æ•°æ®å’Œç®€å•æ ‡ç­¾çš„åŸºçº¿æ–¹æ³•ã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶ä¸»è¦åº”ç”¨äºŽç™Œç—‡é¢„åŽé¢„æµ‹å’Œä¸ªæ€§åŒ–åŒ»ç–—é¢†åŸŸï¼Œå¯è¾…åŠ©ä¸´åºŠåŒ»ç”Ÿè¯„ä¼°æ‚£è€…ç”Ÿå­˜é£Žé™©ï¼Œä¼˜åŒ–æ²»ç–—å†³ç­–ã€‚æ½œåœ¨ä»·å€¼åŒ…æ‹¬æé«˜é¢„æµ‹å‡†ç¡®æ€§ã€å‡å°‘æ•°æ®å†—ä½™å½±å“ï¼Œä»¥åŠé€šè¿‡çŸ¥è¯†å¢žå¼ºæå‡æ¨¡åž‹å¯è§£é‡Šæ€§ï¼ŒæŽ¨åŠ¨ç²¾å‡†åŒ»ç–—å‘å±•ã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Current multimodal survival prediction methods typically rely on pathology images (WSIs) and genomic data, both of which are high-dimensional and redundant, making it difficult to extract discriminative features from them and align different modalities. Moreover, using a simple survival follow-up label is insufficient to supervise such a complex task. To address these challenges, we propose KEMM, an LLM-driven Knowledge-Enhanced Multimodal Model for cancer survival prediction, which integrates expert reports and prognostic background knowledge. 1) Expert reports, provided by pathologists on a case-by-case basis and refined by large language model (LLM), offer succinct and clinically focused diagnostic statements. This information may typically suggest different survival outcomes. 2) Prognostic background knowledge (PBK), generated concisely by LLM, provides valuable prognostic background knowledge on different cancer types, which also enhances survival prediction. To leverage these knowledge, we introduce the knowledge-enhanced cross-modal (KECM) attention module. KECM can effectively guide the network to focus on discriminative and survival-relevant features from highly redundant modalities. Extensive experiments on five datasets demonstrate that KEMM achieves state-of-the-art performance. The code will be released upon acceptance.

